Just as a blueprint, since the oncogenic Bcl-2 hinders both apoptosis and autophagy by Bax and Beclin 1 inhibition, its decreased expression in response to “ruthenotherapy” could be somehow involved in re-activation of mechanisms of cell death in BCC. Here, BAX is linked to skin basal cell carcinoma.